|Articles|July 20, 2022
mRNA 5’ cap characterization using LC-HRAM-MS
Author(s)Thermo Fisher Scientific
The 5’ capping is a CQA for mRNA vaccines and therapeutics, and needs to be fully characterized. Learn a sensitive, robust LC-HRAM-MS/MS method for identification and quantitation of 5’ cap.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
FAQ: Shifts in FDA Regulations and Strategies in 2025
4
Charles River Incubator Cohort to Accelerate CGT Development
5
